Bruce Hiscock Acquires 61 Shares of Bioventix PLC (LON:BVXP) Stock

Bioventix PLC (LON:BVXP) insider Bruce Hiscock acquired 61 shares of the company’s stock in a transaction dated Monday, December 23rd. The shares were bought at an average cost of GBX 273 ($3.42) per share, with a total value of £166.53 ($208.87).

Bruce Hiscock also recently made the following trade(s):

• On Friday, November 22nd, Bruce Hiscock bought 24 shares of Bioventix stock. The stock was purchased at an average price of GBX 3,822 ($47.94) per share, with a total value of £917.28 ($1,150.48).
• On Wednesday, October 30th, Bruce Hiscock purchased 300 shares of Bioventix stock. The shares were acquired at an average price of GBX 3,330 ($41.77) per share, with a total value of £9,990 ($12,529.79).

Bioventix Price Performance

Shares of Bioventix stock opened at GBX 3,174.76 ($39.82) on Thursday. Bioventix PLC has a one year low of GBX 2,977 ($37.34) and a one year high of GBX 5,100 ($63.97). The business’s 50 day simple moving average is GBX 3,621.85 and its two-hundred day simple moving average is GBX 3,982.76. The stock has a market capitalization of £165.72 million, a P/E ratio of 1,947.70 and a beta of 0.35.

Bioventix Increases Dividend

The company also recently disclosed a dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were given a GBX 87 ($1.09) dividend. This is a boost from Bioventix’s previous dividend of $68.00. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 2.4%. Bioventix’s payout ratio is presently 9,693.25%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.